All Stories

  1. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy

    Article • mBio, May 2018, ASM Journals

    Dr William Jacobs

  2. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice

    Article • Antimicrobial Agents and Chemotherapy, January 2018, ASM Journals

    Dr William Jacobs

  3. Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application

    Article • mBio, March 2017, ASM Journals

    Dr William Jacobs

  4. Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal PreexistingMycobacterium tuberculosisPersistent Cells in Human Sputum

    Article • mBio, October 2016, ASM Journals

    Dr William Jacobs

  5. Fluorescent Reporter DS6A Mycobacteriophages Reveal Unique Variations in Infectibility and Phage Production in Mycobacteria

    Article • Journal of Bacteriology, September 2016, ASM Journals

    Dr William Jacobs

  6. Postprimary Tuberculosis and Macrophage Necrosis: Is There a Big ConNECtion?

    Article • mBio, January 2016, ASM Journals

    Dr Ka-Wing Wong, Dr William Jacobs

  7. The Complete Genome Sequence of the Emerging Pathogen Mycobacterium haemophilum Explains Its Unique Culture Requirements

    Article • mBio, November 2015, ASM Journals

    Dr William Jacobs

  8. Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease

    Article • eLife, March 2015, eLife

    Dr William Jacobs, Mr Christopher Petro, Angèle Bénard

  9. Genetic Manipulations Using Phages

    Article • April 2014, ASM Journals

    Dr William Jacobs

  10. Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive Mycobacterium tuberculosis

    Article • mBio, May 2013, ASM Journals

    Dr William Jacobs